GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » Equity-to-Asset

EXMceuticals (FRA:9OM1) Equity-to-Asset : -1.28 (As of Mar. 2021)


View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. EXMceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2021 was €-1.09 Mil. EXMceuticals's Total Assets for the quarter that ended in Mar. 2021 was €0.85 Mil.

The historical rank and industry rank for EXMceuticals's Equity-to-Asset or its related term are showing as below:

FRA:9OM1's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

EXMceuticals Equity-to-Asset Historical Data

The historical data trend for EXMceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Equity-to-Asset Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 -13.20 0.56 0.21 -5.50

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.40 -5.50 -0.56 -1.24 -1.28

Competitive Comparison of EXMceuticals's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EXMceuticals's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where EXMceuticals's Equity-to-Asset falls into.



EXMceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

EXMceuticals's Equity to Asset Ratio for the fiscal year that ended in Jun. 2020 is calculated as

Equity to Asset (A: Jun. 2020 )=Total Stockholders Equity/Total Assets
=-4.511/0.82
=

EXMceuticals's Equity to Asset Ratio for the quarter that ended in Mar. 2021 is calculated as

Equity to Asset (Q: Mar. 2021 )=Total Stockholders Equity/Total Assets
=-1.085/0.847
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EXMceuticals  (FRA:9OM1) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


EXMceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (FRA:9OM1) Business Description

Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines